Daily Health Headlines

Brain Differences Seen in Young Adults at Genetic Risk of Alzheimer's

👤by Amy Norton 0 comments 🕔Friday, October 23rd, 2015

THURSDAY, Oct. 22, 2015 (HealthDay News) -- Young adults who have an increased genetic risk for Alzheimer's disease may already show differences in how their brains handle spatial navigation, a small study suggests.

The researchers said it's too soon to know whether the brain differences are a harbinger of Alzheimer's.

"That is still unclear and needs to be investigated in further studies," said senior researcher Dr. Nikolai Axmacher, of the German Center for Neurodegenerative Diseases, in Bonn.

But the hope, he said, is that the findings will improve researchers' understanding of the earliest processes that lead to Alzheimer's -- the most common form of dementia.

And if the brain differences do turn out to predict Alzheimer's disease years later, that information could be used to pinpoint high-risk people early, Axmacher added.

Other researchers said the findings were important, because everyone wants to find reliable biological signs that indicate a person has a high risk of Alzheimer's later in life.

The study, published in the Oct. 23 issue of Science, involved 75 young adults, half of whom carried a variant of the APOE gene that is believed to boost the risk of Alzheimer's.

It's estimated that one in six people carry the variant, known as APOE4, Axmacher said. They have a threefold greater risk of Alzheimer's than non-carriers do.

The researchers used an advanced form of MRI to study a brain area known as the entorhinal cortex, which contains so-called "grid cells." Those cells, Axmacher explained, are important in spatial navigation -- one of the first skills to go awry when Alzheimer's begins.

The team tracked activity in those grid cells as study participants navigated a "virtual" task that gauged their spatial memory: They had to remember the spatial location of objects in a virtual arena, then place those objects in the correct place.

It turned out that, on average, the APOE4 carriers showed less functioning in their grid cells during the task, versus young adults who did not carry the gene variant.

Still, both groups performed similarly on the test.

That raised the question of whether APOE4 carriers tended to compensate by using other brain regions to navigate, the study authors noted.

"Indeed, we found that the less intact the grid cell system was, the more active an adjacent brain area, the hippocampus [was]," Axmacher said.

What's more, he added, the APOE4 carriers tended to show a different strategy during the test: Typically, they navigated from a vantage point along the border of the virtual arena, while non-carriers preferred to operate from the center.

Exactly what it all could mean is unclear. But, Axmacher said, other research has hinted that excess activity in the hippocampus is part of the process that leads to Alzheimer's.

"These findings are interesting and exciting," said Dr. Luco Gilberto, a neurologist with North Shore-LIJ's Cushing Neuroscience Institute, in Manhasset, N.Y.

The results have to be confirmed in larger studies, Gilberto said. And longer-term work is needed to see whether the reduced grid cell function actually predicts Alzheimer's.

"Right now, we have no therapies that prevent Alzheimer's," Gilberto said. But if and when such treatments become available, doctors will need reliable ways to pinpoint high-risk individuals who could benefit.

Biological markers are also needed to find the best candidates for clinical trials testing experimental therapies, Gilberto said.

Dean Hartley, director of science initiatives for the Alzheimer's Association, agreed that the study results hint at a possible new biological marker.

He said the findings also offer more clues about the roots of Alzheimer's, which could help in developing new therapies.

"The field is trying to figure out, when does this disease process really begin?" Hartley said.

Researchers already know that abnormal proteins called "plaques" can be present in the brain 20 years before any symptoms of Alzheimer's arise, Hartley pointed out.

The latest findings, he said, add to evidence that the disease is a decades-long "continuum."

Article Credits / Source

Amy Norton / HealthDay

Amy Norton wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Nikolai Axmacher, M.D., German Center for Neurodegenerative Diseases, Bonn, Germany; Dean Hartley, Ph.D., director, science initiatives, Alzheimer's Association, Chicago; Luca Gilberto, M.D., Ph.D., attending neurologist, Cushing Neuroscience Institute, North Shore-LIJ Health System, Manhasset, N.Y.; Oct. 23, 2015, Science

View More Articles From Amy Norton 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Alzheimer's Disease Articles

Fewer Americans Suffering From Dementia, Study Finds

Fewer Americans Suffering From Dementia, Study Finds0

MONDAY, Nov. 21, 2016 (HealthDay News) -- Here's some good news for America's seniors: Dementia rates have dropped dramatically over the last decade or so, according to a new study. An analysis of responses from a study of more than 10,000 ...

Can Occupational Therapy Slow Alzheimer's Decline?

Can Occupational Therapy Slow Alzheimer's Decline?0

MONDAY, Nov. 21, 2016 (HealthDay News) -- Home-based occupational therapy may not slow down the physical decline that comes with Alzheimer's disease, a new clinical trial suggests. The study looked at whether home visits from occupational ...

Poor Sense of Smell May Signal Alzheimer's Risk

Poor Sense of Smell May Signal Alzheimer's Risk0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A person's sense of smell may help predict their risk for Alzheimer's disease, a new study suggests. The researchers included 183 older people, and 10 had possible or probable Alzheimer's disease, ...

Some Elderly With Alzheimer's Brain Plaques Stay Sharp

Some Elderly With Alzheimer's Brain Plaques Stay Sharp0

MONDAY, Nov. 14, 2016 (HealthDay News) -- In a discovery that challenges conventional thinking, researchers report that several people over the age of 90 had excellent memory even though their brains showed signs that they had Alzheimer's ...

Brain Scans May Improve Dementia Diagnosis, Treatment

Brain Scans May Improve Dementia Diagnosis, Treatment0

TUESDAY, Nov. 8, 2016 (HealthDay News) -- Tens of millions of people worldwide suffer from memory loss and mental impairment due to dementia. While there's no cure, medication may temporarily improve some symptoms. Proper treatment, however, depends ...

View More Alzheimer's Disease Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!